In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $472.16, denoting a -1.48% move from the preceding trading day.
The average of price targets set by Wall Street analysts indicates a potential upside of 29.7% in Intuitive Surgical (ISRG). While the effectiveness of this highly sought-after metric is questionable,
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $479.27, marking a -2.76% move from the previous day.
ISRG targets cardiac surgery as a long-term da Vinci 5 growth driver after FDA clearance, eyeing nearly 160,000 potential procedures in cleared markets vs approximately 17,000 today.
Intuitive Surgical is initiated with a Buy rating and a $584.87 price target, reflecting 19% upside potential. ISRG's business model benefits from robust recurring revenues in consumables and services

Intuitive Surgical Stock: Buy, Sell, or Hold?

12:03am, Thursday, 12'th Mar 2026
Intuitive Surgical's fourth-quarter revenue increased 19% year over year. Management guided for a notable deceleration in worldwide da Vinci procedure growth in 2026.
Intuitive Surgical (ISRG) remains the robotic-assisted surgery market leader, with Q4 procedures up 18% and revenue rising 19% to $2.87 billion. ISRG's recurring revenue model, high margins, and $3B n
Citi is making a clear statement about the health of U.S. medical technology heading into the spring: the sector's fundamentals remain intact, even as broader market volatility has dragged down some o
ISRG rides da Vinci 5 momentum as procedure volumes surge, global adoption expands and Ion and SP platforms boost recurring revenue growth into 2026.
Pre-Market Stock Futures: Futures are trading lower as we hit the mid-point of the trading week, and while we didn't see the snapback rally that was the star of the show Monday, at least all four majo

2 Growth Stocks to Hold for the Next Decade

03:27pm, Tuesday, 10'th Mar 2026
Intuitive Surgical is plenty able to navigate its current issues while capitalizing on growing demand for its devices. DexCom's total installed base is a fraction of its addressable market, giving it
ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Aptus Capital Advisors LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 8.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE